🔗 Share this article

As America continues making historic changes to its vaccine guidelines, a particular individual has surfaced in a surprising turn: Tracy Beth Høeg, an American of Danish descent sports medicine doctor and epidemiologist who initially gained attention by questioning COVID-19 vaccinations throughout the pandemic and has zeroed in on possible deaths following COVID-19 immunization in her short time at the FDA.

Scheduled Overhauls to Childhood Vaccine Program

Public health authorities were set to unveil major revisions to the childhood vaccination calendar in December, aligning the US with the Danish national calendar, sources say – a major change that would put the US out of step with a large portion of the world with no evidence for public health gain. This reveal has been delayed until the coming year.

Instead of the top vaccines chief, Dr. Høeg is set to speak at the gathering. She was newly appointed interim head of the FDA’s CDER, the fifth person to run the center this calendar year.

Consolidating Power at the FDA

Høeg's temporary position could signify a closer partnership between the pharmaceutical and biologics centers as Dr. Høeg and Prasad consolidate power at the FDA – and it signals a renewed priority upon reevaluating previously authorized immunizations at the FDA.

Dr. Høeg has frequently advocated for halting certain childhood shot schedules in the US in order to be more similar to the Danish model, a nation with nationalized medicine and a citizenry roughly the size of Wisconsin’s.

To date comments, she has kept her attention on immunizations – typically the purview of Prasad, director of the FDA’s CBER – rather than medication approval.

Doubts Over Qualifications

The appointee has little discernible track record in drug development, regulation or administrative roles, which has been customary for former leaders of the biologics center. She has been employed at the FDA as a top consultant to the agency head and the vaccine center since March.

“She doesn’t seem to have any of the qualifications” for leading the pharmaceutical oversight division, remarked Dr. Jonathan Howard. “She has not conducted a scientific study. She lacks experience in managing a major agency. She lacks background in pharmaceutical oversight.”

Former commissioners of the center would “grasp regulatory frameworks and the science of drug development”, commented a former acting FDA commissioner. “Objectively, she doesn’t have the sort of resume that prior appointees who led the center have had.”

The drug center has an vast range of responsibilities at the agency, the former commissioner stated.

“The public just zeroes in on the innovative therapies, but the off-patent medication office clears a multitude of generic drugs. There is also a biosimilars division, OTC medication office and more, and each of these must be looked after,” Dr. Woodcock explained. “The responsibility you neglect, that’s the thing that I always told people is going to bite you.”

There is also, a significant leadership element to the role, which manages more than 5,000 personnel. “It’s a massive leadership role, if you do it right,” she concluded.

Response and Contentious Policies

In response to inquiries about Høeg’s qualifications and whether this assignment signifies increased cooperation among regulatory chiefs on immunizations, a representative said that the “inquiries stem from inaccurate assumptions”.

“Her resume is consistent with the functions of her role,” the official explained, pointing to the months Dr. Høeg spent counseling the agency head on “pharmaceutical safety and regulatory science, including computerized risk analysis and shot safety tracking”.

In her interim role, Dr. Høeg inherits the commissioner’s recently launched priority voucher program, a controversial expedited therapy clearance system that allegedly concerned her former heads. “How are these therapies being selected for this voucher program? Who makes the decisions?” Howard asked. “There’s a lot of secrecy going on at the agency right now.”

Broadly speaking, he stated, “the Food and Drug Administration seems to be moving towards laxer regulations of most medications, with the exception of immunizations.”

Established History on Immunizations

With vaccines, Dr. Høeg has a clearer, if concerning, history, Howard have noted. She released a study using unconfirmed crowd-sourced reports to determine the frequency of myocarditis following COVID-19 immunization. She counseled the Florida surgeon general Joseph Ladapo, who allegedly have changed statistics to imply COVID-19 vaccines are pose a greater threat than they are.

Among her “policy goals” for the new administration featured revising rules for recently developed shots and halting “non-essential” immunizations, she said following the vote on a audio program. At the agency, Høeg has allegedly proposed excluding adolescent males from receiving Covid vaccinations.

“She is an thorough dogmatist who starts off with her conclusions and reverse-engineers to retrofit the data in a highly disingenuous, untruthful manner,” Dr. Howard argued.

Gaining Influence and a “Revenge Tour”

Høeg aligned with other skeptics, {like|